Lindsay F. Schwartz, MD, MS
Attending Physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation
Assistant Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine
- Language:
- English
- Pronouns:
- she
- her
- hers
- Accepting New Patients:
-
Yes
-
Offering Virtual Care:
-
Yes
Location
Ann & Robert H. Lurie Children's Hospital of Chicago
225 E. Chicago Ave.Chicago, Illinois 60611
About Me
"It is my privilege to walk alongside our young people and their families in their cancer journey. I never take their trust for granted, and it inspires both my care and my commitment to finding better treatments for brighter futures."
Dr. Lindsay Schwartz is a pediatric oncologist and physician scientist at Ann & Robert H. Lurie Children's Hospital of Chicago. She received her medical degree from University of Illinois College of Medicine in 2015. She then completed her residency in Pediatrics at the University of California, Los Angeles (UCLA) in 2018, and returned to Chicago to complete her Pediatric Hematology/Oncology fellowship training at the University of Chicago in 2022. During her fellowship, she obtained a Master of Science in Public Health Sciences, also from the University of Chicago. She joined the Division of Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation at Lurie Children's in 2025.
Dr. Schwartz’s clinical interests include caring for children, teenagers, and young adults with leukemia, lymphoma, lymphoproliferative disorders, and histiocytic neoplasms. She also treats long-term survivors of all childhood, adolescent, and young adult cancers.
Dr. Schwartz’s research investigates the impact of health behaviors and psychosocial factors on long-term health outcomes of childhood, adolescent, and young adult cancer survivors. She also evaluates clinical outcomes of young patients with rare types of non-Hodgkin lymphoma, who are often ineligible for clinical trials. Lastly, she studies long-term fertility issues that young patients receiving gonadotoxic therapies may face as cancer survivors. She is a member of the Children’s Oncology Group (COG) Non-Hodgkin Lymphoma and Outcomes/Survivorship committees, serving on the COG Long-Term Follow Up Guidelines Taskforce. Her research has received grants from the National Cancer Institute (NCI) and United States Department of Defense (DOD), and Dr. Schwartz is the prior recipient of the 2021 International Society of Pediatric Oncology (SIOP) Young Investigator Award and the 2024 American Society of Pediatric Hematology/Oncology (ASPHO) Young Investigator Award.
Clinical Interests
Leukemia, lymphoma, lymphoproliferative disorders, histiocytic neoplasms, cancer survivorship, oncofertility
Specialty
Education & Training
Education: University of Illinois College of Medicine, 2015
Postgraduate Training: Fellowship in pediatric hematology/oncology, University of Chicago, 2019-2022; Residency in pediatrics, University of California Los Angeles (UCLA), 2015-2018
Board Certifications: Pediatrics; Pediatric Hematology/Oncology
Professional Organizations: American Society of Clinical Oncology, American Society of Hematology, American Society of Pediatric Hematology Oncology, Children's Oncology Group, International Society of Pediatric Oncology, Histiocyte Society